Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Rises By 19.9%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) was the recipient of a large growth in short interest during the month of June. As of June 15th, there was short interest totalling 89,800 shares, a growth of 19.9% from the May 31st total of 74,900 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Basilea Pharmaceutica Stock Performance

Shares of Basilea Pharmaceutica stock remained flat at $48.15 on Friday. The company’s fifty day moving average is $46.60 and its two-hundred day moving average is $42.82. Basilea Pharmaceutica has a 1-year low of $38.60 and a 1-year high of $48.15.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.